olmesartan

4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid

VTRAEEWXHOVJFV-UHFFFAOYSA-N CHEBI:48416 8 Reactome links 4 studies

4 Observed studies

4 Observed diff profiles

8 Reactome pathways

Metabolite details

Identifier: VTRAEEWXHOVJFV-UHFFFAOYSA-N
InChI Key: VTRAEEWXHOVJFV-UHFFFAOYSA-N
IUPAC name: 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid
Preferred name: olmesartan
INN name: —
Synonym: 4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
ChEBI: CHEBI:48416

Reactome pathways

R-HSA-1430728 - Metabolism
R-HSA-162582 - Signal Transduction
R-HSA-211859 - Biological oxidations
R-HSA-211945 - Phase I - Functionalization of compounds
R-HSA-372790 - Signaling by GPCR
R-HSA-373076 - Class A/1 (Rhodopsin-like receptors)
R-HSA-375276 - Peptide ligand-binding receptors
R-HSA-500792 - GPCR ligand binding

Observed in studies

Observed in differential profiles